Dual Antitubercular and Antileishmanial Profiles of Quinoxaline Di-
N-oxides
antileishmanial
antitubercular
co-infections
drug design
neglected tropical diseases
structure–activity relationships
Journal
Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453
Informations de publication
Date de publication:
11 Apr 2024
11 Apr 2024
Historique:
received:
19
03
2024
revised:
02
04
2024
accepted:
07
04
2024
medline:
27
4
2024
pubmed:
27
4
2024
entrez:
27
4
2024
Statut:
epublish
Résumé
We present a new category of quinoxaline di-N-oxides (QdNOs) containing amino acid side chains with dual antituberculosis and antileishmanial activity. These compounds were synthesized by combining a regioselective 2,5-piperazinedione opening and a Beirut reaction and were screened for their activity against
Identifiants
pubmed: 38675447
pii: ph17040487
doi: 10.3390/ph17040487
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Ministerio de Ciencia e Innovación
ID : TED2021-129408B-I00